Class I and II HDACi Romidepsin potentiates the effects of TMZ, inducing apoptosis of GBM cells by increasing the expression of pro-apoptotic genes and restraining the PI3K/Akt pathway both in vitro and in vivo [192]. The gene discussed is AKT1; the disease is glioblastoma.